News & Views

13th January 2017

Large Specialist Care Operator sold at a high multiple

Cambian Group has agreed a deal with Cygnet Health Care to sell its adult services business in a transaction worth £377m.

Kent based mental health services provider Cygnet has 21 centres with more than 1,000 beds across the UK.

It reportedly took control of the disposed business at 11.5x earnings however some sources have claimed that the multiple was as high as 15x.

This deal shows a buoyant market for scale operators in the specialist care sector and is positive news for participants, like the Montreux Healthcare Fund, which are seeking to further consolidate the market before exit.

Montreux is the majority investor in The Regard Group, one of the UK’s leading providers of quality residential care and supported living services to over 1000 service users across more than 145 sites.

Oliver Harris CEO of Montreux Capital Management (UK), the firm which advises the Montreux Healthcare Fund stated:

“This transaction shows a buoyant UK Specialist Care Market as this asset class continues to attract considerable investment from both UK and overseas based institutional investors.

We are seeing strong activity in UK Specialist Care as investors switch from the high end elderly space, where we have seen high valuations in an overheating market due to the finite amount of purpose built facilities available. Unlike the high end elderly space, the specialist care sector is not geographically constrained and continues to offer value to investors.

The activity within the sector is good news for Montreux and its investors who already own a large national platform which we are looking to grow further to create the largest premier specialist care operator in the UK."


The information on this site is intended only for the use of Independent Financial Advisors (IFAs) and other professionally recognised financial intermediaries & institutions.. Should you proceed to access this site, you will be representing and warranting that you are an IFA or other professionally recognised financial intermediary . What follows is not an offer or invitation to acquire an investment and should therefore not be relied upon by, any person in any jurisdiction where such an offer or invitation would be unlawful. Persons in respect of whom such prohibitions apply must not access this web site. None of the information contained on this site constitutes personal recommendations nor advice. Product details should always be read in conjunction with the appropriate offering documents. An application for any of the investment products on this page should be made having fully read not only the relevant application form, but also the relevant terms and conditions and offering documents. If you are unsure about the meaning of any information provided on this web page, then please consult your financial or other professional adviser. We do not offer investment advice.

This web site may contain or be linked to advice or statements of third parties. We make no representation as to the accuracy, completeness, timeliness or suitability of such information, and we have not and will not review or update such information and caution you that any use made of such information is at your own risk. Some of the information contained on this web site may also have been prepared or provided by third parties and may not have been verified by us. We hereby exclude any liability arising out of any preparation or provision of such information for the web site and makes no warranty as to the accuracy, suitability or completeness of any such information.

I agree, Continue

Information on this webpage relates to and is provided by Montreux Capital Management (UK) Limited

The content of this webpage should not be construed as financial advice. Any decision to invest should be made only on the basis of the relevant documentation for each investment. Past performance is not necessarily a guide to future performance. The value of an investment may go down as well as up and investors may not get back the full amount invested. Investments in small unquoted companies carry an above-average level of risk. These investments are highly illiquid and as such, there may not be a readily available market to sell such an investment. Montreux Capital Management (UK) Limited and Sapia Partners LLP (together "the Sponsors," or "Sponsor) do not provide specific individual advice on the suitability of investments with regard to a potential investor's individual circumstances, risk tolerance or investment objectives and investors should seek independent financial advice if they are in any doubt whether a product is suitable for them.

Montreux Capital Management (UK) Limited is an Appointed Representative of Sapia Partners LLP which is authorised and regulated by the Financial Conduct Authority.

I agree, Continue